APA (7th ed.) Citation

Peimanfard, S., Zarrabi, A., Trotta, F., Matencio, A., Cecone, C., & Caldera, F. (2022). Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host–Guest Complexes in a Comparative Evaluation. Pharmaceutics, 14(5), 1059. https://doi.org/10.3390/pharmaceutics14051059

Chicago Style (17th ed.) Citation

Peimanfard, Shohreh, Ali Zarrabi, Francesco Trotta, Adrián Matencio, Claudio Cecone, and Fabrizio Caldera. "Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host–Guest Complexes in a Comparative Evaluation." Pharmaceutics 14, no. 5 (2022): 1059. https://doi.org/10.3390/pharmaceutics14051059.

MLA (9th ed.) Citation

Peimanfard, Shohreh, et al. "Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host–Guest Complexes in a Comparative Evaluation." Pharmaceutics, vol. 14, no. 5, 2022, p. 1059, https://doi.org/10.3390/pharmaceutics14051059.